Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence
- PMID: 29800999
- DOI: 10.1001/jama.2018.4914
Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence
Comment on
-
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710. JAMA. 2018. PMID: 29801017
-
Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2018 May 8;319(18):1914-1931. doi: 10.1001/jama.2018.3712. JAMA. 2018. PMID: 29801018 Review.
Similar articles
-
Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening.Urol Oncol. 2023 Feb;41(2):76-77. doi: 10.1016/j.urolonc.2022.04.001. Epub 2022 May 4. Urol Oncol. 2023. PMID: 35523706 Review. No abstract available.
-
Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.Radiol Clin North Am. 2018 Mar;56(2):187-196. doi: 10.1016/j.rcl.2017.10.002. Epub 2017 Nov 26. Radiol Clin North Am. 2018. PMID: 29420975 Review.
-
Unravelling the prostate-specific antigen controversy: a West of Scotland perspective.Scott Med J. 2014 May;59(2):126-9. doi: 10.1177/0036933014528618. Epub 2014 Mar 28. Scott Med J. 2014. PMID: 24682103
-
[PSA-based prostate cancer screening, a slippery slope].Rev Prat. 2018 Oct;68(8):832-838. Rev Prat. 2018. PMID: 30869445 French. No abstract available.
-
Beyond the PSA test: How to better stratify a patient's risk of prostate cancer.JAAPA. 2017 Aug;30(8):51-54. doi: 10.1097/01.JAA.0000521148.78442.d5. JAAPA. 2017. PMID: 28742748
Cited by
-
Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer.Front Oncol. 2022 Jul 12;12:911725. doi: 10.3389/fonc.2022.911725. eCollection 2022. Front Oncol. 2022. PMID: 35903679 Free PMC article.
-
Magnetic Levitation of Personalized Nanoparticle-Protein Corona as an Effective Tool for Cancer Detection.Nanomaterials (Basel). 2022 Apr 19;12(9):1397. doi: 10.3390/nano12091397. Nanomaterials (Basel). 2022. PMID: 35564106 Free PMC article.
-
Clinical value of prostate-specific antigen combined with tumor abnormal protein (TAP) in the diagnosis of prostate puncture.Transl Cancer Res. 2020 Jan;9(1):58-64. doi: 10.21037/tcr.2019.11.05. Transl Cancer Res. 2020. PMID: 35117158 Free PMC article.
-
The Role and Clinical Potentials of Circular RNAs in Prostate Cancer.Front Oncol. 2021 Nov 5;11:781414. doi: 10.3389/fonc.2021.781414. eCollection 2021. Front Oncol. 2021. PMID: 34804984 Free PMC article. Review.
-
ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement.Res Involv Engagem. 2021 Nov 17;7(1):81. doi: 10.1186/s40900-021-00322-w. Res Involv Engagem. 2021. PMID: 34789334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous